NCAPG2 and cancer: Our findings revealed a strong positive correlation between NCAPG2 and the immune checkpoints in several cancer types, including BLCA, GBMLGG, HNSC, KIRC, KIPAN, LIHC, OV, PRAD, PAAD, and UVM (P < 0.05).